No Data
No Data
Teyi Pharmaceutical Group (002728.SZ) has repurchased 1.18% of the shares.
On July 16th, Gelonhui reported that Teyi Pharmaceutical Group (002728.SZ) repurchased 6,005,260 shares of the company through the Shenzhen Stock Exchange trading system using centralized bidding trading method as of July 16, 2024, accounting for 1.18% of the total share capital. The highest repurchase price was 8.03 yuan/share and the lowest was 7.22 yuan/share. The total amount paid was RMB 44.2134 million (excluding related transaction fees).
Teyi Pharmaceutical Group: 2024 Interim Performance Forecast
Teyi Pharmaceutical Group (002728.SZ): Net income is expected to decrease by 97.90%-98.49% in the first half of the year.
On July 8, Gelunhui reported that Teyi Pharmaceutical Group (002728.SZ) announced the performance forecast for the first half of 2024. The net income attributable to shareholders of the listed company during the reporting period was RMB 2.3 million to RMB 3.2 million, down 98.49% to 97.90% from the same period last year. The net income after deducting non-recurring gains and losses was RMB 1.8 million to RMB 2.7 million, down 98.80% to 98.21% from the same period last year. The basic earning per share was RMB 0.005/share to RMB 0.006/share. During this reporting period, the company had a marketing organizational change, optimizing and adjusting the original organizational structure and marketing channels. Communication
Teyi Pharmaceutical Group (002728.SZ) bought back 258,000 shares for the first time, involving 2.03696 million yuan.
On June 24th, Gelunhui reported that Teyi Pharmaceutical Group (002728.SZ) announced its first share buyback through a centralized bidding transaction on the Shenzhen Stock Exchange trading system on June 24, 2024. The company repurchased 258,000 shares, accounting for 0.05% of the company's current total share capital. The highest price of the repurchase transaction was 7.91 yuan/share, the lowest price was 7.88 yuan/share, and the total amount paid was RMB 2.03696 million (excluding relevant transaction fees).
Teyi Pharmaceutical to Buy Back Up to 120 Million Yuan Shares; Shares Up 3%
Teyi Pharmaceutical Group (SHE:002728) plans to repurchase shares worth between 70 million yuan and 120 million yuan, the company said in a Wednesday disclosure on the Shenzhen Stock Exchange. The Chi
Teyi Pharmaceutical Group (002728.SZ) plans to spend 70-120 million yuan to repurchase company shares.
On June 11th, Gelonhui reported that Teyi Pharmaceutical Group (002728.SZ) plans to repurchase the company's issued common stock (A shares) for stock-based incentives or employee stock ownership plans. The total amount of repurchase funds is not less than RMB 70 million (inclusive) and not more than RMB 120 million (inclusive). The repurchase price is no more than RMB 12.96/share (inclusive). Based on the upper limit of the repurchase price of RMB 12.96/share, it is estimated that the range of the minimum and maximum repurchase quantity is about 5,401,234 shares to 9,259,259 shares, which account for the total share capital of the company.
No Data